Kewalramani Reshma Insider Trading Activity
Kewalramani Reshma has been net-selling over the last 12 months with 2 purchases and 13 sales across 1 company.
VRTX is the most-traded position with 15 trades. The largest single transaction was a sale of VRTX for $7.7M on Feb 27, 2026.
Performance Scorecard
Forward stock performance after each transaction by Kewalramani Reshma. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | +1.7% | +9.5% | 100% | 15 |
| 90 days | +8.3% | +8.5% | 100% | 15 |
| 120 days | +17.4% | — | 100% | 2 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersVRTX · VERTEX PHARMACEUTICALS INC / MA
🔒 Subscribe to see trade entries
Pro members see exactly when Kewalramani Reshma bought and sold VRTX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | ROLE |
|---|---|---|---|---|---|---|
| Feb 27, 2026 | VRTX | Sell | 400 | $479.75 | $192K | CEO |
| Feb 27, 2026 | VRTX | Sell | 120 | $481.50 | $58K | CEO |
| Feb 27, 2026 | VRTX | Sell | 240 | $482.84 | $116K | CEO |
| Feb 27, 2026 | VRTX | Sell | 2,510 | $487.13 | $1.2M | CEO |
| Feb 27, 2026 | VRTX | Sell | 3,278 | $488.27 | $1.6M | CEO |
| Feb 27, 2026 | VRTX | Sell | 460 | $489.32 | $225K | CEO |
| Feb 27, 2026 | VRTX | Sell | 2,725 | $490.54 | $1.3M | CEO |
| Feb 27, 2026 | VRTX | Sell | 949 | $491.30 | $466K | CEO |
| Feb 27, 2026 | VRTX | Sell | 2,520 | $493.29 | $1.2M | CEO |
| Feb 27, 2026 | VRTX | Sell | 3,498 | $494.33 | $1.7M | CEO |
| Feb 27, 2026 | VRTX | Sell | 15,580 | $495.38 | $7.7M | CEO |
| Feb 27, 2026 | VRTX | Sell | 5,995 | $496.16 | $3.0M | CEO |
| Feb 27, 2026 | VRTX | Sell | 1,725 | $496.95 | $857K | CEO |
| Aug 6, 2025 | VRTX | Buy | 4,290 | $389.08 | $1.7M | CEO |
| Aug 6, 2025 | VRTX | Buy | 5,710 | $389.95 | $2.2M | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| VRTX | VERTEX PHARMACEUTICALS INC / MA | 15 | $23.6M |
Other insiders at VERTEX PHARMACEUTICALS INC / MA
10 other tracked filers at VRTX.